Flerie AB (FRA:1NP1) FFO


FRA:1NP1 Flerie AB FRA:1NP1
27 GF Score
Price €1.72
! 1 Warning Sign
View Full Analysis

What is Flerie AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1NP1
27GF Score
Flerie AB FRA:1NP1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Flerie AB Business Description

Other Exchanges FLERIE:Sweden1NP1:Germany
Address Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. It operates in two segments The Product Development segment, and The Commercial Growth segment. The Product Development segment consists of early and mid-stage biotech and pharma companies advancing their products and technologies toward clinical proofof-concept and marketing approvals. The Commercial Growth segment consists of companies already selling products or services, showcasing their ability to generate increasing revenues ahead of reaching sustainable profitability.
27GF Score

Get the complete analysis for FRA:1NP1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.72
Price